Is there a patent application for the biosynthesis of sitagliptin?
Yes. The phrase “biosynthesis of sitagliptin” is most commonly used in patent filings that describe producing sitagliptin (or key intermediates used to make it) using biological systems (for example, engineered enzymes, whole-cell biocatalysis, or fermentation-based steps). Patent applications can cover both the biomanufacturing route and downstream chemical purification/finishing steps.
What does “biosynthesis of sitagliptin” typically mean in patent applications?
In sitagliptin-related patent documents, “biosynthesis” usually refers to one or more steps carried out via biological catalysts rather than only traditional purely chemical synthesis. These documents may describe:
- Enzymes that convert one intermediate to another with fewer chemical steps.
- Whole-cell or fermentation processes that generate chiral intermediates.
- Hybrid routes where a biosynthetic step makes a specific chiral building block, and then standard chemical chemistry completes sitagliptin formation and purification.
If you share the application number, assignee (company), or a patent title/abstract excerpt, I can help interpret exactly which intermediates and organisms/enzymes are claimed.
How do you find the exact sitagliptin “biosynthesis” patent application?
A practical way to locate the specific application is to search patent databases using combinations of these terms:
- “sitagliptin” + “biosynthesis” (or “biocatalysis,” “enzyme,” “whole cell,” “fermentation,” “microorganism”)
- “sitagliptin” + intermediate names commonly used in sitagliptin routes
- assignee names associated with sitagliptin manufacturing and process improvements
For patent- and exclusivity-focused tracking (which can help identify what’s publicly published and who holds rights), DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/
Why do biosynthesis/process patents matter for sitagliptin?
Process patents can be used to protect improvements that reduce cost, improve yield, or make chiral intermediates more efficiently. Even when the final drug is the same (sitagliptin), different manufacturing routes can lead to different patentable claims.
What to send if you want the exact application details
To pinpoint the correct “biosynthesis of sitagliptin” patent application, provide any one of the following:
- the application publication number (e.g., WO…, EP…, US…)
- the patent title (even partial)
- the applicant/assignee name
- the abstract text you found
Then I can extract what the claims cover (the biological step(s), the specific intermediates, and the claimed organisms/enzymes) and explain how it differs from standard chemical synthesis.
Sources
- DrugPatentWatch.com